236P Adjuvant osimertinib in resected EGFR-mutated NSCLC: A real-world analysis from the Italian ATLAS registry
ESMO Open · 2026-04 · 11 · 106544
DOI: 10.1016/j.esmoop.2026.106544 ↗Kurz gefasst
Fachartikel in der Zeitschrift ESMO Open, 2026-04. Verfasst von M.L. Reale und 18 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Reale, M., Passiglia, F., Andrikou, K., Vavala, T., Catania, C., Chiari, R., Grisanti, S., Roca, E., Alì, G., Calvetti, L., Gelibter, A., Catino, A., Belluomini, L., Veccia, A., Giannarelli, D., Malapelle, U., Novello, S., Tiseo, M., & Pasello, G. (2026). 236P Adjuvant osimertinib in resected EGFR-mutated NSCLC: A real-world analysis from the Italian ATLAS registry. ESMO Open, 11, 106544. https://doi.org/10.1016/j.esmoop.2026.106544
Vancouver
Reale M, Passiglia F, Andrikou K, Vavala T, Catania C, Chiari R, et al. 236P Adjuvant osimertinib in resected EGFR-mutated NSCLC: A real-world analysis from the Italian ATLAS registry. ESMO Open. 2026;11:106544. doi:10.1016/j.esmoop.2026.106544
BibTeX
@article{Reale2026,
author = {Reale, M.L. and Passiglia, F. and Andrikou, K. and Vavala, T. and Catania, C.M. and Chiari, R. and Grisanti, S. and Roca, E. and Alì, G. and Calvetti, L. and Gelibter, A.J. and Catino, A.M. and Belluomini, L. and Veccia, A. and Giannarelli, D. and Malapelle, U. and Novello, S. and Tiseo, M. and Pasello, G.},
title = {236P Adjuvant osimertinib in resected EGFR-mutated NSCLC: A real-world analysis from the Italian ATLAS registry},
journal = {ESMO Open},
year = {2026},
volume = {11},
pages = {106544},
doi = {10.1016/j.esmoop.2026.106544}
}
EUVIMED